EUVIMEDEUVIMED entdecken
Crossref

Therapeutic targeting of SATB2 for treating hepatocellular carcinoma

K. Pandav, S. Srivastava, Z. Ahmed, N. Landry, A. Shrivastava, R. Srivastava

European Journal of Cancer · 2026-11 · 248 · 118164

DOI: 10.1016/j.ejca.2026.118164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von K. Pandav und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Pandav, K., Srivastava, S., Ahmed, Z., Landry, N., Shrivastava, A., & Srivastava, R. (2026). Therapeutic targeting of SATB2 for treating hepatocellular carcinoma. European Journal of Cancer, 248, 118164. https://doi.org/10.1016/j.ejca.2026.118164

Vancouver

Pandav K, Srivastava S, Ahmed Z, Landry N, Shrivastava A, Srivastava R. Therapeutic targeting of SATB2 for treating hepatocellular carcinoma. European Journal of Cancer. 2026;248:118164. doi:10.1016/j.ejca.2026.118164

BibTeX
@article{Pandav2026,
  author = {Pandav, K. and Srivastava, S. and Ahmed, Z. and Landry, N. and Shrivastava, A. and Srivastava, R.},
  title = {Therapeutic targeting of SATB2 for treating hepatocellular carcinoma},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {118164},
  doi = {10.1016/j.ejca.2026.118164}
}
Kostenlos starten →